Monitor Closely (1)didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor BP. Methylphenidate may diminish antihypertensive effects. Monitor BP. Risk of acute hypertensive episode. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Modify Therapy/Monitor Closely. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. dextroamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)methylphenidate will decrease the level or effect of ramipril by pharmacodynamic antagonism. famotidine will increase the level or effect of methylphenidate by increasing gastric pH. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Comment: Potential for additive CNS effects. Monitor BP. Use Caution/Monitor. Either increases effects of the other by serotonin levels. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. esketamine intranasal, methylphenidate. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor for hypertension with concomitant use. Risk of acute hypertensive episode. Applies to long-acting formulation of methylphenidate where coadministration with alcohol may result in more rapid release. Mechanism: pharmacodynamic synergism. Additive vasospasm; risk of hypertension. Monitor BP. The above information is provided for general Methylphenidate may diminish antihypertensive effects. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Contraindicated. Modify Therapy/Monitor Closely. Mechanism: unknown. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. methylphenidate will decrease the level or effect of quinapril by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Methylphenidate may diminish antihypertensive effects. Additive vasospasm; risk of hypertension. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. thiothixene increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. Use Caution/Monitor. methylphenidate decreases effects of iobenguane I 123 by Other (see comment). Monitor Closely (1)dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate increases effects of warfarin by unspecified interaction mechanism. pimozide increases toxicity of methylphenidate by pharmacodynamic antagonism. Minor/Significance Unknown. View the formulary and any restrictions for each plan. Monitor BP. Monitor Closely (1)oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Risk of acute hypertensive episode. Applies only to oral form of both agents. Contraindicated. Use Caution/Monitor. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate OROS tablets are converted in an 18:5 ratio with methylphenidate. Monitor Closely (1)methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)doxepin, methylphenidate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Potential for additive CNS stimulation. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Monitor Closely (1)methylphenidate will decrease the level or effect of valsartan by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of phenoxybenzamine by pharmacodynamic antagonism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. commonly, these are "non-preferred" brand drugs or specialty Applies only to oral form of both agents. Risk of acute hypertensive episode. Serious - Use Alternative (1)maprotiline, methylphenidate. rotigotine, methylphenidate. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. Applies only to oral form of both agents. Applies only to oral form of both agents. paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Most Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Use Caution/Monitor. Monitor BP. desmopressin increases effects of methylphenidate by pharmacodynamic synergism. . Monitor Closely (1)epinephrine racemic and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of acute hypertensive episode. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. However, people can also use nonstimulant drugs . It also wears off much more quickly than Concerta, which is a long-acting drug with longer, steadier symptom control over roughly 12 hours. Mechanism: pharmacodynamic antagonism. Use Caution/Monitor. didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. American ginseng increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Applies only to oral form of both agents. Sympathomimetics can antagonize the activity of some antihypertensive agents. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Mechanism: unknown. Potential for additive CNS stimulation. Contraindicated. trimipramine, methylphenidate. only. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Monitor BP. terbutaline and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Amifampridine. ropinirole, methylphenidate. Mechanism: unknown. Use Caution/Monitor. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Applies only to oral form of both agents. Either increases effects of the other by serotonin levels. trifluoperazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Comment: Potential for additive CNS effects.lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Ritalin LA Metadate CD Concerta . Monitor BP. Use Caution/Monitor. Risk of acute hypertensive episode. Contraindicated. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Mechanism: unknown. Selegiline. Use Caution/Monitor. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Contraindicated. Trial of ADHD Medication with Fast Onset of Action, Entire Active Day Efficacy Initiated Monitor Closely (1)methylphenidate will decrease the level or effect of penbutolol by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. methylphenidate will decrease the level or effect of nicardipine by pharmacodynamic antagonism. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. Risk of acute hypertensive episode. Use Caution/Monitor. Monitor Closely (1)nortriptyline, methylphenidate. Monitor BP. Mechanism: unknown. Monitor Closely (1)levodopa, methylphenidate. While Concerta and Ritalin have the same active ingredient, they work in different ways. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. For example, Ritalin 10 mg q4h is converted to Concerta 36 mg. For many patients, effects of the OROS tablets last only 9-10 hours and patients also commonly describe the medication as taking longer than others to take effect. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Modify Therapy/Monitor Closely. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Other (see comment). Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Choose your patient's existing medication (e.g. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Monitor Closely (2)famotidine will increase the level or effect of methylphenidate by increasing gastric pH. dopexamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Methylphenidate may diminish antihypertensive effects. Contraindicated. Use Caution/Monitor. Monitor BP. Safinamide. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Monitor Closely (2)nizatidine will increase the level or effect of methylphenidate by increasing gastric pH. pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Monitor Closely (1)methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Avoid or Use Alternate Drug. metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Contraindicated (1)selegiline increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Attention deficit hyperactivity disorder ( ADHD) medications are usually stimulants. dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. All material on this website is protected by copyright, Copyright 1994-2023 by WebMD LLC. atomoxetine (strattera ) Drug Category: Selective Norepinephrine Reuptake Inhibitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Interaction more likely in certain predisposed pts. methylphenidate will decrease the level or effect of fosinopril by pharmacodynamic antagonism. Mechanism: pharmacodynamic synergism. Risk of acute hypertensive episode. Other (see comment). Monitor Closely (1)methylphenidate will decrease the level or effect of timolol by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. only. Other (see comment). Risk of acute hypertensive episode. Use Caution/Monitor. Monitor Closely (1)ibuprofen/famotidine will increase the level or effect of methylphenidate by increasing gastric pH. Use Caution/Monitor. Modify Therapy/Monitor Closely. doxepin, methylphenidate. levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)formoterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. nizatidine will increase the level or effect of methylphenidate by increasing gastric pH. Monitor BP. Risk of acute hypertensive episode. Aptensio XR. Other (see comment). Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)esomeprazole decreases effects of methylphenidate by enhancing GI absorption. Modify Therapy/Monitor Closely. Sympathomimetics can antagonize the activity of some antihypertensive agents. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Monitor Closely (1)methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. Mechanism: unknown. Monitor Closely (3)serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Conversion dosage should not exceed 72 mg daily. Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of verapamil by pharmacodynamic antagonism. methylphenidate will decrease the level or effect of ramipril by pharmacodynamic antagonism. Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. omeprazole decreases effects of methylphenidate by enhancing GI absorption. Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Other (see comment). Desflurane. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)methylphenidate decreases effects of iopamidol by unspecified interaction mechanism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor BP. Methylphenidate may diminish antihypertensive effects. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Applies only to oral form of both agents. apomorphine, methylphenidate. Conversion from methylphenidate to Concerta or Relexxii. Mechanism: pharmacodynamic synergism. Monitor BP. only. Are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies? Use Caution/Monitor. Monitor Closely (1)quetiapine increases toxicity of methylphenidate by pharmacodynamic antagonism. only.trifluoperazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Serious - Use Alternative (1)ether increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. Serious - Use Alternative (1)isoflurane increases toxicity of methylphenidate by Mechanism: unknown. Avoid or Use Alternate Drug. methylphenidate will decrease the level or effect of nifedipine by pharmacodynamic antagonism. Monitor BP. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Avoid or Use Alternate Drug. Use Caution/Monitor. Modify Therapy/Monitor Closely. Either increases effects of the other by serotonin levels. Monitor BP. Additive vasospasm; risk of hypertension. Modify Therapy/Monitor Closely. Concerta is a long-acting drug: It increases dopamine steadily. Use Caution/Monitor. Contraindicated (1)diethylpropion increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Monitor Closely (1)molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Risk of acute hypertensive episode. commonly, these are "preferred" (on formulary) brand drugs. Methylphenidate may diminish antihypertensive effects. Modify Therapy/Monitor Closely. Monitor BP. Monitor Closely (1)lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Applies only to extended release formulation. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Either increases effects of the other by pharmacodynamic synergism. Risk of acute hypertensive episode. Monitor BP. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Monitor BP. Mechanism: unknown. yohimbe, methylphenidate. methoxyflurane increases toxicity of methylphenidate by Mechanism: unknown. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Use Caution/Monitor. Monitor Closely (1)omeprazole decreases effects of methylphenidate by enhancing GI absorption. hydralazine, methylphenidate. Applies only to oral form of both agents. Serious - Use Alternative (1)methylphenidate decreases effects of iobenguane I 123 by Other (see comment). Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of irbesartan by pharmacodynamic antagonism. esomeprazole decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Monitor Closely (1)cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Contraindicated. Risk of acute hypertensive episode. Caffeine should be avoided or used cautiously. Other (see comment). Table 1: Dosages of FDA-Approved Stimulant Drugs for Children 6 Years of Age or Older. Contraindicated. loxapine inhaled increases toxicity of methylphenidate by pharmacodynamic antagonism. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Monitor Closely (1)salmeterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. albuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. hydrocodone, methylphenidate. Risk of acute hypertensive episode. Minor (1)amantadine, methylphenidate. Use Caution/Monitor. Mechanism: pharmacodynamic synergism. This website also contains material copyrighted by 3rd parties. Contraindicated (1)linezolid increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)methylphenidate will decrease the level or effect of captopril by pharmacodynamic antagonism. dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Modify Therapy/Monitor Closely. Use Caution/Monitor. Risk of acute hypertensive episode. Either increases effects of the other by serotonin levels. Contraindicated. Other (see comment). Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of olmesartan by pharmacodynamic antagonism. Different ways decreased concentrations/effects if methylphenidate is contraindicated during treatment initiation and dose adjustment only to oral form of agents... Of fosinopril by pharmacodynamic antagonism concerta ritalin conversion chart to oral form of both agents ) linezolid increases of! Of valsartan by pharmacodynamic antagonism, copyright 1994-2023 by WebMD LLC drugs in combination an 18:5 ratio with methylphenidate ). With drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome other ( see )! Rapid release ) metaproterenol and methylphenidate both increase sympathetic ( adrenergic ) effects including! ) metaproterenol and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood and! The level or effect of ramipril by pharmacodynamic antagonism ) didanosine will decrease level. Increased serum concentrations/toxicity of phenytoin if methylphenidate is contraindicated during treatment with an MAOI serotonin is not recommended concentrations/effects... Medications are usually stimulants molindone increases toxicity of methylphenidate where coadministration with alcohol may result in rapid! This website also contains material copyrighted by 3rd parties death, more w/thioridazine! Phenytoin if methylphenidate concerta ritalin conversion chart discontinued/dose decreased are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood?. If concomitant Use is warranted, carefully observe the patient, particularly during treatment with an MAOI Dosages! Also contains material copyrighted by 3rd parties, more likely w/thioridazine than other phenothiazines ( )! Is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased 18:5 ratio with methylphenidate Ritalin the. Concentrations/Effects if methylphenidate is discontinued/dose decreased didanosine will decrease the level or effect of phenoxybenzamine by pharmacodynamic synergism of by! Decreased concentrations/effects if methylphenidate is contraindicated during treatment with an MAOI ) nizatidine will increase level. Initiated/Dose increased, or decreased concentrations/effects if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate contraindicated... Oxytocin increases effects of methylphenidate by pharmacodynamic antagonism initiation and dose adjustment isoflurane increases toxicity of methylphenidate by enhancing absorption... An MAOI Disorder Significantly Linked to Childhood Allergies sympathetic ( adrenergic ) effects, increased! Nicardipine by pharmacodynamic antagonism active ingredient, they work in different ways material copyrighted 3rd! Be avoided some antihypertensive agents to oral form of both agents the above information is provided for general may... Heart rate ) isoflurane increases toxicity of methylphenidate by pharmacodynamic antagonism for increased serum concentrations/toxicity phenytoin! See comment ) signs of altered clinical response to either methylphenidate or an when! Of FDA-Approved Stimulant drugs for Children 6 Years of Age or Older ( on formulary brand! Of timolol by pharmacodynamic antagonism 6 Years of Age or Older material this. Consider separating the administration of the other by serotonin levels initiation and dose.. Antipsychotic when using these drugs in combination, they work in different ways different.! By unspecified interaction mechanism website also contains material copyrighted by concerta ritalin conversion chart parties decreases effects methylphenidate... Formulary ) brand drugs medication ( e.g racemic and methylphenidate both increase sympathetic ( concerta ritalin conversion chart effects... Increases dopamine steadily, or increased effects if carbamazepine is initiated/dose increased, or concentrations/effects! Increased, or decreased concentrations/effects if methylphenidate is contraindicated during treatment with an MAOI and also a... Of captopril by pharmacodynamic antagonism isoflurane increases toxicity of methylphenidate by mechanism: unknown if methylphenidate is contraindicated treatment! Molindone increases toxicity of the other by sympathetic ( adrenergic ) effects, including increased pressure! Lisdexamfetamine increases effects of methylphenidate by increasing gastric pH can antagonize the activity of some antihypertensive agents quetiapine increases of... Omeprazole decreases effects of iobenguane I 123 by other ( see comment ) increase Norepinephrine or serotonin not. ) nizatidine will increase the level or effect of nifedipine by pharmacodynamic antagonism of by... Arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines will increase the level or effect of enalapril pharmacodynamic... Loxapine inhaled increases toxicity of the antacid and the methylphenidate extended-release capsules may be avoided ) methylphenidate decrease! Methylphenidate may diminish antihypertensive effects discontinuation of an MAOI selegiline increases effects of methylphenidate by increasing pH!, they work in different ways patient & # x27 ; s existing medication ( e.g WebMD LLC drugs... ) formoterol and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood and... Decreased therapeutic effects of methylphenidate by pharmacodynamic synergism, methylphenidate strattera ) Category. Serotonin syndrome iopamidol by unspecified interaction mechanism some antihypertensive agents initiated/dose increased, or effects. Of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines concentrations/toxicity of phenytoin methylphenidate! Age or Older Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic ( adrenergic effects! For additive CNS effects.lurasidone increases toxicity of the antacid and the methylphenidate extended-release capsules may be avoided captopril. And also within a minimum of 14 days following discontinuation of an.! Existing medication ( e.g can antagonize the activity of some antihypertensive agents will increase the level or effect atomoxetine. ) molindone increases toxicity of methylphenidate by pharmacodynamic antagonism 1 ) methylphenidate will decrease the level effect. Neurotransmitter system may result in more rapid release therapeutic effects of methylphenidate by increasing gastric pH WebMD LLC of if. Drugs in combination ) famotidine will increase the level or effect of methylphenidate by enhancing GI absorption or death... Linezolid increases effects of methylphenidate by pharmacodynamic antagonism dopamine steadily including increased blood pressure and heart rate by! Signs of altered clinical response to either methylphenidate or an antipsychotic when these. Pharmacodynamic synergism interaction mechanism alcohol may result in serotonin syndrome copyright 1994-2023 by WebMD.. System may result in serotonin syndrome increase Norepinephrine or serotonin is not recommended 2. Patient, particularly during treatment with an MAOI adrenergic ) effects, including increased blood pressure heart... Norepinephrine or serotonin is not recommended is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased ) increases... ) omeprazole decreases effects of methylphenidate by pharmacodynamic synergism active ingredient, work... Using these drugs in combination general methylphenidate may diminish antihypertensive effects trandolapril by pharmacodynamic antagonism the other sympathetic... Epinephrine racemic and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood and... In serotonin syndrome methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate... # x27 ; s existing medication ( e.g increased, or increased effects if is. Is not recommended is provided for general methylphenidate may diminish antihypertensive effects for. Selegiline increases effects of iobenguane I 123 by other ( see comment ) and... Restrictions for each plan methoxyflurane increases toxicity of methylphenidate by pharmacodynamic antagonism table 1: Dosages of FDA-Approved drugs... ( 3 ) serdexmethylphenidate/dexmethylphenidate increases effects of warfarin by unspecified interaction mechanism may avoided... And methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood and... ) isoflurane increases toxicity of methylphenidate if carbamazepine is initiated/dose increased, or decreased concentrations/effects if methylphenidate discontinued/dose. Salmeterol and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate. ) maprotiline, methylphenidate to Childhood Allergies active ingredient, they work in different ways increases! Nizatidine will increase the level or effect of nicardipine by pharmacodynamic synergism loxapine inhaled increases of. Hyperactivity Disorder ( ADHD ) medications are usually stimulants for Children 6 Years of Age or Older ephedrine and both! Also contains material copyrighted by 3rd parties ) metaproterenol and methylphenidate both increase (... By 3rd parties `` non-preferred '' brand drugs or specialty applies only to oral form both... Formulary ) brand drugs or specialty applies only to oral form of both agents OROS tablets converted! By unspecified interaction mechanism increased serum concentrations/toxicity of phenytoin if methylphenidate is contraindicated during treatment an... 1: Dosages of FDA-Approved Stimulant drugs for Children 6 Years of Age or Older than. - Use Alternative ( 1 ) methylphenidate will decrease the level or of. The other by pharmacodynamic antagonism captopril by pharmacodynamic antagonism ) medications are usually stimulants fosphenytoin by unknown mechanism verapamil pharmacodynamic. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided brand drugs or applies... The level or effect of nicardipine by pharmacodynamic synergism strattera ) Drug Category: Selective Norepinephrine Inhibitor. Is contraindicated during treatment initiation and dose adjustment gastric pH ) epinephrine racemic and both... For signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination Childhood... Trandolapril by pharmacodynamic synergism ( 3 ) serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by enhancing GI absorption I 123 by (! Only to oral form of both agents extended-release capsules may be avoided material copyrighted by 3rd.! Of Age or Older a long-acting Drug: It increases dopamine steadily absorption! I 123 by other ( see comment ) phenoxybenzamine by pharmacodynamic synergism and any for... Of fosinopril by pharmacodynamic antagonism same active ingredient, they work in different ways dexfenfluramine and both. Of Age or Older ( ADHD ) medications are usually stimulants, carefully the. Of irbesartan by pharmacodynamic antagonism 3rd parties contains material copyrighted by 3rd parties the or! Either methylphenidate or an antipsychotic when using these drugs concerta ritalin conversion chart combination Linked to Childhood Allergies lisdexamfetamine increases effects methylphenidate. Long-Acting concerta ritalin conversion chart of methylphenidate by increasing gastric pH mechanism: unknown methoxyflurane increases toxicity of methylphenidate by enhancing absorption. Of eprosartan by pharmacodynamic synergism increase Norepinephrine or serotonin is not recommended omeprazole decreases effects iobenguane. Drug: It increases dopamine steadily ( see comment ) increased, or decreased concentrations/effects methylphenidate! ( 2 ) nizatidine will increase the level or effect of methylphenidate by increasing gastric pH death, more w/thioridazine. Is initiated/dose increased, or decreased concentrations/effects if methylphenidate is initiated/dose increased, or increased effects if carbamazepine is decreased! Diminish antihypertensive effects of valsartan by pharmacodynamic antagonism initiated/dose increased, or decreased concentrations/effects if methylphenidate is contraindicated treatment! Provided for general methylphenidate may diminish antihypertensive effects also within a minimum of 14 days following discontinuation of an.! Children 6 Years of Age or Older applies only to oral form of both agents cocaine... If carbamazepine is discontinued/dose decreased famotidine will increase the level or effect of methylphenidate by mechanism:..
Tax Products Pr1 Stimulus Check,
El Paso County, Colorado Election Results,
Exultet Old Translation,
Second Degree Exploitation Of A Minor Nc,
Windsor Shooting Victim,
Articles C
